Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
lactose
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III extreme morbid obesity 
with weight of 441.1 pounds as of ___ with her initial 
screen weight on ___ as 444 pounds at height of 64.25 
inches and BMI of 75.1.  Her previous weight loss efforts have 
included Weight Watchers multiple times, ___, 
Nutrisystem, Slim-Fast, ___ and ___ diets, Overeaters 
Anonymous (OA), over-the-counter dietary ___ 
visits.  She has not taken prescription weight loss medications. 
 She stated that her lowest adult weight was 330 pounds at the 
age of ___ and her highest weight was 448 pounds last year.  
She weighed 425 pounds in ___. She stated that she has been 
struggling with weight since the age of ___ and cites as factors 
contributing to her excess weight genetics, large portions, 
inconsistent meal pattern especially on weekends, too many 
carbohydrates and saturated fats, convenience eating, emotional 
eating, grazing, late night eating, and lack of exercise.  She 
denied history of eating disorders - no anorexia, bulimia, 
diuretic or laxative abuse but she did admit to being G without 
purge and that used to be 3 times a week and then 4 times a 
month that she has cut back on.  She does have depression and 
anxiety, unipolar with no panic attacks and has been followed by 
a therapist on the recommendation of our bariatric MSW.  She has 
experienced trauma from when she was a child but she has worked 
on this in counseling.  She has not been hospitalized for mental 
health issues but she has had intensive outpatient follow-up due 
to depression and suicidal ideation last in ___.  She is on
psychotropic medications (bupropion and trazodone).

 
Past Medical History:
1)  asthma considered seasonal with no recent prednisone taper
2)  irritable bowel syndrome
3)  history of elevated blood pressure
4)  obstructive sleep apnea on CPAP but does not use regularly
5)  low back pain
6)  vitamin D deficiency
7)  iron deficiency with saturation of 18%
8)  mild hyperuricemia
9)  hepatic steatosis by ultrasound study
10) carpal tunnel syndrome
11) allergic rhinitis
12) knee instability
13) history of oligomenorrhea/amenorrhea followed by GYN
14) history of alcohol abuse in remission since ___ (attends 
AA)

Her surgical history includes:

1)  endometrial biopsy in ___
2)  ___ right eye correction ___ and redo ___

 
Social History:
___
Family History:
Her family history is noted for father deceased age ___ of a MI; 
mother living age ___ with fibroids; brother age ___ alive and 
well; there is a history of breast CA in 2 maternal great aunts.

 
Physical Exam:
GEN: A&Ox3, NAD, resting comfortably 
HEENT: NCAT, EOMI, sclera anicteric
CV: RRR
PULM: no respiratory distress
ABD: soft, appropriately tender, ND, no rebound or guarding 
EXT: warm, well-perfused, no edema 
PSYCH: normal insight, memory, and mood
WOUND(S): Incision c/d/i
 
Pertinent Results:
___ 02:19AM BLOOD Hct-39.6
___ 05:17PM BLOOD Hct-42.7
 
Brief Hospital Course:
The patient presented to pre-op on ___ for scheduled 
laparoscopic sleeve gastrectomy. Patient was evaluated by 
anaesthesia.  

The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  

 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  

 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  

 Pulmonary: The patient was kept overnight in the PACU due to 
her OSA and large BMI. The patient remained stable from a 
pulmonary standpoint; vital signs were routinely monitored. Good 
pulmonary toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  

 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  

 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  

 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  

 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  The patient was then 
discharged on enoxaparin 60 mg BID for 30 days due to her 
significant BMI for DVT prophylaxis.

 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. BuPROPion 100 mg PO TID 
2. Cyclobenzaprine 5 mg PO HS:PRN back pain/ spasms 
3. Fluticasone Propionate NASAL 2 SPRY NU QHS:PRN allergy 
symptoms 
4. Multivitamins 1 TAB PO DAILY 
5. MedroxyPROGESTERone Acetate 5 mg PO ASDIR 
6. Cetirizine 10 mg PO DAILY 
7. albuterol sulfate 90 mcg/actuation inhalation ASDIR 
8. Ascorbic Acid ___ mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium (Liquid) 100 mg PO BID constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  Enoxaparin Sodium 60 mg SC Q12H 
RX *enoxaparin 60 mg/0.6 mL 60 mg SC twice a day Disp #*60 
Syringe Refills:*0 
4.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
5.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Severe 
RX *oxycodone 5 mg/5 mL 5 ml by mouth every four (4) hours 
Refills:*0 
6.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
7.  Ascorbic Acid ___ mg PO DAILY  
8.  BuPROPion 100 mg PO TID  
9.  Cetirizine 10 mg PO DAILY  
10.  Fluticasone Propionate NASAL 2 SPRY NU QHS:PRN allergy 
symptoms  
11.  Multivitamins 1 TAB PO DAILY  
12. HELD- Cyclobenzaprine 5 mg PO HS:PRN back pain/ spasms  This 
medication was held. Do not restart Cyclobenzaprine until you 
are no longer taking oxycodone.
13. HELD- MedroxyPROGESTERone Acetate 5 mg PO ASDIR  This 
medication was held. Do not restart MedroxyPROGESTERone Acetate 
until you discuss with Dr. ___ your gynecologist.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You have undergone a laparoscopic sleeve gastrectomy, recovered 
in the hospital and are now preparing for discharge to home with 
the following instructions:

Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:

1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.

2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.

3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.

4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.

5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

ANTICOAGULATION:
You are being prescribed enoxaparin (Lovenox) 60 mg twice per 
day for thirty days in duration to prevent blood clots. You 
should administer these injections as directed. 

 
Followup Instructions:
___